retatrutide safety profile clinical trials A new trial from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one of the next major medications in the rapidly growing weight loss and diabetes glp-1 medications nutrient deficiency skin barrier Size:Small ~6 cm

retatrutide safety profile clinical trials A new trial from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one of the next major medications in the rapidly growing weight loss and diabetes glp-1 medications nutrient deficiency skin barrier Size:Small ~6 cm

glp-1 medications nutrient deficiency effects Nutritional priorities to support therapy for obesity: a joint Advisory

While there is no evidence that GLP-1 medications stimulate testosterone production directly, the increase in testosterone driven by their weight-loss effects appears comparable to that of other weight loss strategies

skin barrier

Size:Small ~6 cm

In patients with active or poorly controlled disease, GLP-1 medications can theoretically worsen gastrointestinal symptoms through their effect on stomach emptying and gut motility